BD
BioAdaptives Inc.
BDPT · OTC
$0.00 +4.00% (+$0.00)
1M -27.78%
Market Cap $15.6K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0013
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BDPT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.61x
P/E N/A
EV/EBITDA N/A
Growth
30 /100
Declining Rev. growth 2.09%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 74.48%
Net margin 4,553.73%
FCF margin 1,097.43%
Quality
63 /100
Average ROIC 73.00%
ROA 1,477.75%
Asset turnover 0.32x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -48.33x
Debt/Equity N/A
Stability
22 /100
Unstable Beta 1.20x
Rev. volatility 64.99%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BDPT
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
James Keener
Employees
1
Headquarters
Las Vegas